Literature DB >> 23814080

An overview of respiratory problems in children with Down's syndrome.

Rachel Watts1, H Vyas.   

Abstract

Respiratory disease is a common cause of morbidity and mortality in children with Down's syndrome (DS). Causes range from those problems common to many children with DS, such as a narrow airway or impaired immunity, to rare structural lesions, such as tracheal bronchus. Additionally, other organ systems or extrinsic factors may play a role. A thorough understanding of the range of potential problems will aid in the evaluation and management of children with DS and respiratory symptoms.

Entities:  

Mesh:

Year:  2013        PMID: 23814080     DOI: 10.1136/archdischild-2013-304611

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  11 in total

1.  Prenatal histological, cellular, and molecular anomalies in trisomy 21 lung.

Authors:  Soula Danopoulos; Soumyaroop Bhattacharya; Gail Deutsch; Lina R Nih; Chris Slaunwhite; Thomas J Mariani; Denise Al Alam
Journal:  J Pathol       Date:  2021-06-23       Impact factor: 9.883

2.  Increased Lung Expression of Anti-Angiogenic Factors in Down Syndrome: Potential Role in Abnormal Lung Vascular Growth and the Risk for Pulmonary Hypertension.

Authors:  Csaba Galambos; Angela D Minic; Douglas Bush; Dominique Nguyen; Blair Dodson; Gregory Seedorf; Steven H Abman
Journal:  PLoS One       Date:  2016-08-03       Impact factor: 3.240

Review 3.  Limited Evidence on the Management of Respiratory Tract Infections in Down's Syndrome: A Systematic Review.

Authors:  Logan Manikam; Kate Reed; Roderick P Venekamp; Andrew Hayward; Peter Littlejohns; Anne Schilder; Monica Lakhanpaul
Journal:  Pediatr Infect Dis J       Date:  2016-10       Impact factor: 2.129

4.  Effects of Pidotimod on recurrent respiratory infections in children with Down syndrome: a retrospective Italian study.

Authors:  Diletta Valentini; Chiara Di Camillo; Nadia Mirante; Valentina Marcellini; Rita Carsetti; Alberto Villani
Journal:  Ital J Pediatr       Date:  2020-03-13       Impact factor: 2.638

5.  Lower airway microbiota in children with Down syndrome compared to controls with similar respiratory symptomatology.

Authors:  Mariska De Lausnay; Stijn Verhulst; Lieve Boel; Kim Van Hoorenbeeck
Journal:  Transl Pediatr       Date:  2021-07

Review 6.  Underlying factors of recurrent infections in patients with down syndrome.

Authors:  Turkan Patiroglu; Murat Cansever; Fulya Bektas
Journal:  North Clin Istanb       Date:  2018-01-29

7.  Respiratory tract infection-related healthcare utilisation in children with Down's syndrome.

Authors:  Logan Manikam; Anne G M Schilder; Monica Lakhanpaul; Peter Littlejohns; Emma C Alexander; Andrew Hayward
Journal:  Infection       Date:  2020-03-14       Impact factor: 3.553

Review 8.  Down Syndrome and COVID-19: A Perfect Storm?

Authors:  Joaquin M Espinosa
Journal:  Cell Rep Med       Date:  2020-05-01

9.  Opportunities, barriers, and recommendations in down syndrome research.

Authors:  James A Hendrix; Angelika Amon; Leonard Abbeduto; Stamatis Agiovlasitis; Tarek Alsaied; Heather A Anderson; Lisa J Bain; Nicole Baumer; Anita Bhattacharyya; Dusan Bogunovic; Kelly N Botteron; George Capone; Priya Chandan; Isabelle Chase; Brian Chicoine; Cécile Cieuta-Walti; Lara R DeRuisseau; Sophie Durand; Anna Esbensen; Juan Fortea; Sandra Giménez; Ann-Charlotte Granholm; Laura J Hahn; Elizabeth Head; Hampus Hillerstrom; Lisa M Jacola; Matthew P Janicki; Joan M Jasien; Angela R Kamer; Raymond D Kent; Bernard Khor; Jeanne B Lawrence; Catherine Lemonnier; Amy Feldman Lewanda; William Mobley; Paul E Moore; Linda Pollak Nelson; Nicolas M Oreskovic; Ricardo S Osorio; David Patterson; Sonja A Rasmussen; Roger H Reeves; Nancy Roizen; Stephanie Santoro; Stephanie L Sherman; Nasreen Talib; Ignacio E Tapia; Kyle M Walsh; Steven F Warren; A Nicole White; Guang William Wong; John S Yi
Journal:  Transl Sci Rare Dis       Date:  2021-04-15

10.  Respiratory Syncytial Virus-related Death in Children With Down Syndrome: The RSV GOLD Study.

Authors:  Yvette N Löwensteyn; Emily W E M Phijffer; Juliette V L Simons; Nienke M Scheltema; Natalie I Mazur; Harish Nair; Louis J Bont
Journal:  Pediatr Infect Dis J       Date:  2020-08       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.